Powered by

Covington Advises Salix in $2.6 Billion Acquisition of Santarus

Nov 07, 2013 - PR Newswire
Mergers and Acquisitions

WASHINGTON, Nov. 7, 2013 /PRNewswire/ -- Salix Pharmaceuticals, Ltd., and Santarus, Inc. announced today that the companies have entered into a merger agreement where Salix will acquire all of the outstanding stock of Santarus for $32 in cash per share, for a total value of approximately $2.6 billion. Covington & Burling LLP is advising Salix on both the acquisition and financing aspects of the transaction.

(Logo: http://photos.prnewswire.com/prnh/20120423/CL92331LOGO)

The companies ...